+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Nocturia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768128
  • Report
  • April 2019
  • Region: Global
  • 81 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Accelovance Inc
  • Astellas Pharma Inc
  • Ferring Holding SA
  • OBN UK Ltd
  • Radiant Research Inc
  • Vantia Therap
  • MORE
The global clinical trial report- “2019 Nocturia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturia. It presents in-depth analysis of Nocturia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Nocturia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Nocturia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Nocturia

The research work is prepared through extensive and continuous research on Nocturia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Nocturia patients are identified
  • The report includes panorama of Nocturia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Nocturia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Accelovance Inc
  • Astellas Pharma Inc
  • Ferring Holding SA
  • OBN UK Ltd
  • Radiant Research Inc
  • Vantia Therap
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Nocturia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Nocturia Clinical Trials by Region
2.2.2 Average Enrollment of Nocturia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Nocturia Treatment, 2019

3. Region wise Nocturia Clinical Trials
3.1 Asia Pacific Nocturia Clinical Trials by Country
3.2 Europe Nocturia Clinical Trials by Country
3.3 North America Nocturia Clinical Trials by Country
3.4 Middle East and Africa Nocturia Clinical Trials by Country
3.5 South and Central America Nocturia Clinical Trials by Country

4. Nocturia Clinical Trial Trends
4.1 Start Year wise Nocturia Clinical Trials
4.2 Phase wise Nocturia Clinical Trials
4.3 Trial Status wise Nocturia Clinical Trials
4.4 Trial Type wise Nocturia Clinical Trials

5. Nocturia Average Enrollment Trends
5.1 Average Enrollment in Nocturia Trials by Year
5.2 Average Enrollment in Nocturia Trials by Phase
5.3 Average Enrollment in Nocturia Trials by Status
5.4 Average Enrollment in Nocturia Trials by Type of Trial

6. Companies Participating in Nocturia Clinical Trials
6.1 Nocturia Trials by Sponsor Type
6.2 Nocturia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Nocturia Trials- Phase 1
7.2 Nocturia Trials- Phase 2
7.3 Nocturia Trials- Phase 3
7.4 Nocturia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Nocturia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Nocturia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Nocturia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Nocturia Clinical Trials and Enrolment
Figure 7: North America - Country wise Nocturia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Nocturia Clinical Trials and Enrolment
Figure 9: Nocturia Clinical Trials by Phase
Figure 10: Nocturia Clinical Trials by Trial Status
Figure 11: Nocturia Clinical Trials by Type
Figure 12: Nocturia Clinical Trials by Sponsor Type
Figure 13: Nocturia Clinical Trials by Leading Sponsors
Figure 14: Nocturia Average Enrollment by Phase
Figure 15: Nocturia Average Enrollment by Trial Status
Figure 16: Nocturia Average Enrollment by Type
Figure 17: Nocturia- Average Enrolment by Type of Sponsors
Figure 18: Nocturia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Nocturia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Nocturia Clinical Trials and Enrolment
Table 5: Europe - Country wise Nocturia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Nocturia Clinical Trials and Enrolment
Table 7: North America - Country wise Nocturia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Nocturia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Nocturia Average Enrollment by Phase
Table 15: Nocturia Average Enrollment by Trial Status
Table 16: Nocturia Average Enrollment by Type
Table 17: Nocturia- Average Enrolment by Type of Sponsors
Table 18: Nocturia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Accelovance Inc
  • Astellas Pharma Inc
  • C. H. Boehringer Sohn AG & Co KG
  • Ferring Holding SA
  • Ferring Pharmaceuticals Pty Ltd
  • OBN UK Ltd
  • Pamplona Capital Management LLP
  • Radiant Research Inc
  • Serenity Pharmaceuticals LLC
  • Vantia Therap
Note: Product cover images may vary from those shown
Adroll
adroll